Please use this identifier to cite or link to this item:
|Title:||Changes in oral anticoagulation for elective cardioversion: results from a European cardioversion registry.|
|Citation:||Eur Heart J Cardiovasc Pharmacother.2017 07;(3)3:147-150|
|Abstract:||In patients with atrial fibrillation (AF) pharmacological or electrical cardioversion may be performed to restore sinus rhythm. The procedure is associated with an increased risk of thromboembolic events, which can be significantly reduced by adequate anticoagulation (OAC). Our aim was to create a partly prospective, partly retrospective cardioversion registry, particularly focusing on OAC strategies in different European countries, and on emerging choice of OAC over time.|
|Appears in Collections:||Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.